NeuroPace (NASDAQ:NPCE) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.17) by 52.66 percent. This is a 55.56 percent increase over losses of $(0.18) per share from the same period last year. The company reported quarterly sales of $26.588 million which beat the analyst consensus estimate of $24.791 million by 7.25 percent. This is a 23.86 percent increase over sales of $21.466 million the same period last year.